3D-QSAR CoMFA and CoMSIA studies on a set of diverse α1a-adrenergic receptor antagonists

被引:11
|
作者
Gupta, Amit K. [1 ]
Saxena, Anil K. [1 ]
机构
[1] CSIR, Cent Drug Res Inst, Med & Proc Chem Div, Lucknow 226001, Uttar Pradesh, India
关键词
Adrenergic receptors; 3D-QSAR; CoMFA; CoMSIA; Drug design; MOLECULAR SIMILARITY INDEXES; ALPHA(1)-ADRENOCEPTOR ANTAGONISTS; 1,4-BENZODIOXAN-RELATED COMPOUNDS; 1,3-DIOXOLANE-BASED LIGANDS; PHENOXY ANALOGS; FIELD ANALYSIS; AFFINITY; SUBTYPES; QSAR; DERIVATIVES;
D O I
10.1007/s00044-010-9379-1
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The alpha-adrenergic receptors (alpha-ARs) modulate a number of intracellular processes and among these alpha(1a)-adrenergic receptors play an important role in the regulation of physiological processes related to cardiovascular system. In view of its therapeutic potential, comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) studies were performed on a set of diverse alpha-AR antagonists to understand the structural factors affecting their antagonistic activity where both CoMFA (q (train) (2) = 0.709, r (train) (2) = 0.962, and r (predictive) (2) = 0.629) and CoMSIA (q (train) (2) = 0.648, r (train) (2) = 0.949, and r (predictive) (2) = 0.656) models gave statistical significant results. The generated CoMFA and CoMSIA models suggest that steric, electrostatic and hydrophobic interactions play an important role in describing the variation in antagonistic activity. Therefore, the models may be useful in the identification and optimization of novel scaffolds with potent alpha(1a)-adrenergic receptor antagonistic activity.
引用
收藏
页码:1455 / 1464
页数:10
相关论文
共 50 条
  • [1] 3D-QSAR CoMFA and CoMSIA studies on a set of diverse α1a-adrenergic receptor antagonists
    Amit K. Gupta
    Anil K. Saxena
    Medicinal Chemistry Research, 2011, 20 : 1455 - 1464
  • [2] THREE-DIMENSIONAL IN SILICO PHARMACOPHORE AND COMFA, COMSIA STUDIES ON α1a-ADRENERGIC RECEPTOR ANTAGONISTS
    Gupta, Amit K.
    Doguparthy, Praneeth B.
    Das, Sucheta
    Saxena, Anil K.
    MEDICINAL CHEMISTRY RESEARCH, 2010, 19 : S48 - S49
  • [3] 3D-QSAR STUDIES ON SUBSTITUTED DIHYDROPYRIDINES FOR THEIR α1A-ADRENERGIC RECEPTOR BINDING AFFINITY
    Neeraj Shakya
    Zeeshan Fatima
    Anil K. Saxena
    Medicinal Chemistry Research, 2004, 13 : 812 - 823
  • [4] 3D-QSAR studies on substituted dihydropyridines for their α1A-adrenergic receptor binding affinity
    Shakya, N
    Fatima, Z
    Saxena, AK
    MEDICINAL CHEMISTRY RESEARCH, 2004, 13 (8-9) : 812 - 823
  • [5] 3D-QSAR Analysis of MCD Inhibitors by CoMFA and CoMSIA
    Pourbasheer, Eslam
    Aalizadeh, Reza
    Ebadi, Amin
    Ganjali, Mohammad Reza
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2015, 18 (08) : 751 - 766
  • [6] 3D-QSAR Studies of Novel Cytotoxic Bufadienolides via CoMFA and CoMSIA Approaches
    Lin, Hui
    Li, Shengrong
    Li, Shiyao
    Liu, Kangjia
    Han, Yushui
    Guo, Jialiang
    Lin, Longxin
    Chang, Yiqun
    Xiao, Gaokeng
    Chen, Weimin
    Sun, Pinghua
    LETTERS IN DRUG DESIGN & DISCOVERY, 2017, 14 (03) : 306 - 313
  • [7] 3D-QSAR (CoMFA, CoMSIA) and Molecular Docking Studies on Histone Deacetylase 1 Selective Inhibitors
    Abdizadeh, Tooba
    Ghodsi, Razieh
    Hadizadeh, Farzin
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2017, 12 (04) : 365 - 383
  • [8] 3D-QSAR studies of insecticidal anthranilic diamides as ryanodine receptor activators using CoMFA, CoMSIA and DISCOtech
    Liu, Gen-Yan
    Ju, Xiu-Lian
    Cheng, Jin
    Liu, Zhi-Qiang
    CHEMOSPHERE, 2010, 78 (03) : 300 - 306
  • [9] The 3D-QSAR study of antitumor arylsulfonylimidazolidinone derivatives by CoMFA and CoMSIA
    Choo, HYP
    Choi, S
    Jung, SH
    Koh, HY
    Pae, AN
    BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (21) : 4585 - 4589
  • [10] 3D-QSAR and docking studies on adenosine A2A receptor antagonists by the CoMFA method
    Pourbasheer, E.
    Tabar, S. Shokouhi
    Masand, V. H.
    Aalizadeh, R.
    Ganjali, M. R.
    SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2015, 26 (06) : 461 - 477